Orlistat and Zepbound are two U.S. Food and Drug Administration (FDA)-approved weight loss medications that work in different ...

People considering weight-loss medications might wonder which one works best, and first-of-its-kind research points to an answer. A new study published in the New England Journal of Medicine comparing ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

After 72 weeks of treatment, people taking Zepbound lost about 50 pounds, compared with 33 pounds for those taking Wegovy. The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight ...

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug for ...

Zepbound and Wegovy treat weight loss and weight management in adults with obesity or overweight. Both drugs are also approved to treat other conditions. These drugs are given as weekly injections, ...

Bariatric surgery may confer greater long-term weight loss than semaglutide or tirzepatide for adults with obesity, according ...

Starting July 1, CVS Caremark dropped Zepbound, a GLP-1 weight loss drug, from its preferred coverage on standard plans in favor of Wegovy. Instead of Zepbound, patients are reluctantly trying Wegovy, ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50 percent more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.